Transplant Service Documentation Requirements
Customize your policy alerts
Sign up for WellCare Policy CP.MP.247 alerts
Get alerted when Policy CP.MP.247 changes without checking for updates manually.
Monitor payer policy activity
Defines required clinical documentation for pre-transplant evaluation, transplant listing, and post-transplant follow-up office visit prior authorization requests for solid organ and stem cell/bone marrow transplants for members of WellCare-affiliated health plans.
Clarified in description that the policy applies to transplant evaluation and listing requests.
Added requirements for post-transplant follow up visits and a note regarding other authorization requirements for services unrelated to post-transplant follow-up office visits.
Adjusted time requirement to reflect 12 months for kidney transplants and 6 months for other transplants in documentation timing for history/physical, basic labs, and psychosocial evaluation.
Coverage Criteria
Documentation-based medical necessity criteria
Covered when ALL of the following are met
Approved evaluation requests are effective for six months.
Approved listings are effective for 12 months; transplant admissions require separate authorization.
For authorization requirements for services unrelated to post-transplant follow-up office visits, check the health plan's prior authorization tool.
Supports multiple-authority approvals under specific clinical circumstances.
For corneal transplant, pancreatic islet cell autotransplant after pancreatectomy, and parathyroid autotransplant after thyroidectomy, providers must complete the Health Plan–specific prior authorization form available on the Health Plan website. These specific transplant types are handled via the plan form and are not processed under routine evaluation/listing authorizations described elsewhere in this policy.
Coverage determinations under this policy are subject to the terms, conditions, exclusions and limitations of the member’s coverage documents (for example, evidence of coverage, certificate of coverage, policy or contract). Where applicable, state Medicaid provisions and federal or regulatory requirements take precedence over this clinical policy. This policy is a guide to medical necessity and does not guarantee payment; providers should verify member-specific benefits and applicable legal/regulatory rules when submitting authorization requests.
Coding & Timing
| CPT referenced | CPT codes referenced in policy for informational purposes; specific codes not listed in this part of the document. |
Provider Actions & Authorization Requirements
Prior authorization required for evaluation, listing, and post‑transplant follow‑up
Prior authorization is required for transplant evaluation requests, transplant listing requests, and post‑transplant follow‑up office visits; inpatient transplant admissions require a separate prior authorization.
- Approved transplant evaluation authorizations are effective for six months.
- Approved transplant listing authorizations are effective for 12 months; after 12 months a new authorization with updated documentation is required.
- Inpatient transplant admissions are not covered under evaluation/listing authorizations and must be authorized separately.
Prior authorization must document medical necessity consistent with plan coverage
Authorization requests must include documentation showing the transplant service meets the Health Plan's medical necessity criteria and is consistent with applicable guidance and NCDs/LCDs; providers should verify Medicare/Medicaid‑specific coverage when applicable.
- Authorization requires submission of the specified clinical documentation listed in the policy (history/physical, labs, organ‑specific testing, psychosocial evaluation, etc.).
- Documentation must align with referenced guidelines (UNOS/OPTN, KDIGO, FACT, CMS) and applicable legal/regulatory requirements.
Include prior authorization form and required documentation or risk denial
Requests for transplant evaluation, listing, post‑transplant follow‑up, or continuity‑of‑care authorizations must include the specified prior authorization form and required clinical documentation; failure to include required forms or documentation may result in denial.
- Include the Health Plan’s prior authorization form with every request.
- Lack of required documentation or an appropriate prior authorization form may result in denial of the request.
Coverage terms, exclusions, and legal conflicts may trigger denial
Coverage decisions and benefit administration are subject to all terms, conditions, exclusions, and limitations of the member’s coverage documents; conflicts with state Medicaid/Medicare rules or plan documents may affect coverage and could trigger denial.
- Verify member benefits and any state Medicaid/Medicare requirements; coverage may vary by contract and state law.
- Discrepancies between this policy and coverage documents or legal requirements are resolved in favor of applicable law or plan documents.
Required documentation: evaluation, listing, post‑transplant follow‑up, and continuity of care
Submit the specified clinical documentation for evaluation, listing, post‑transplant follow‑up, and continuity of care authorizations, including history & physical, medication list, basic labs, organ‑specific testing, infectious disease screening, psychosocial evaluation, dental clearance, and prior insurer/UNOS documentation for continuity of care.
- For transplant evaluation: appropriate prior authorization form and a routine complete history and physical within one year (HPI, med list, past medical/family/social history, ROS, physical exam with height, weight, BMI).
- For initial/subsequent listing: prior authorization form; letter of medical necessity signed by transplant service provider; H&P performed by transplant service provider within 12 months for kidney or 6 months for other transplants; basic labs within those timeframes; organ‑specific testing/imaging as listed; annual dental evaluation/clearance; routine health screenings (not required for autologous stem cell transplant); comorbidity testing/clearance; drug screen within 90 days; infectious disease screening within one year as applicable; detailed psychosocial evaluation within 12 months for kidney and 6 months for other transplants.
- For continuity of care: documentation of prior insurer coverage, prior authorization evidence from previous insurer, and a copy of the UNOS listing.
Post‑transplant follow‑up: include prior authorization form and discharge summary/H&P
For post‑transplant follow‑up office visit prior authorization requests, include the appropriate prior authorization form plus the inpatient transplant admission discharge summary or the inpatient history & physical from the transplant admission.
- If requesting authorization for services unrelated to post‑transplant follow‑up office visits, verify separate authorization requirements via the health plan's prior authorization tool.
Submit documentation that supports medical necessity per plan and law
Providers must submit documentation demonstrating medical necessity consistent with the Health Plan’s coverage documents, applicable laws/regulations, and generally accepted standards of medical practice; documentation should reference relevant guidelines as needed.
- Documentation must support that the requested transplant service meets the plan’s medical necessity criteria and align with referenced guidance (UNOS, OPTN, KDIGO, FACT, CMS).
- Providers are responsible for complying with applicable legal and regulatory requirements when submitting documentation.
Requests must include all specified documentation and prior authorization form
Prior authorization requests must include the specific documentation listed in this policy (H&P, labs, organ‑specific testing, infectious disease screening, psychosocial evaluation, dental clearance, drug screen, letter of medical necessity, prior authorization form); missing required items may result in denial.
- Requests for evaluation, listing, post‑transplant follow‑up, or continuity of care must include the specified documentation and prior authorization form.
- Approved evaluation requests are effective for six months; approved listing requests are effective for 12 months—transplant admissions need separate authorization.
Definitions
Organ- and Candidate-Specific Evaluation Requirements
Organ- and transplant-type specific evaluation requirements
Organ-specific and transplant-type specific evaluation items required as part of listing documentation
Infectious disease screening requirements (e.g., CMV, EBV, hepatitis, HIV, RPR, PPD/T-Spot/QuantiFERON) apply as listed.
Annual dental evaluation and psychosocial evaluation timing for kidney listing is within 12 months.
Infectious disease screening also applies as listed.
Infectious disease screening also applies as listed.
C-peptide was removed from criteria per revisions.
Autologous HCT has fewer routine health screening requirements; functional status assessment recommended (ECOG or Karnofsky).
Contraindications
The policy does not enumerate an explicit list of absolute contraindications in this excerpt. It notes that active infection and significant comorbidity may affect transplant candidacy and that such clinical conditions should be considered during evaluation and listing decisions. Transplant admissions are handled separately and require their own prior authorization when applicable.
Evaluation Requirements
Evaluation must include H&P, labs, organ‑specific testing, infectious disease screening, psychosocial, and dental clearance
A complete pre‑transplant evaluation must include a detailed history and physical, basic laboratory testing, organ‑specific testing/imaging as listed, infectious disease screening as applicable, psychosocial evaluation, and dental clearance when required.
- History & physical with HPI, medication list, past medical/family/social history, ROS, and physical exam including height, weight and BMI.
- Basic labs (CBC, chemistry/LFTs) within applicable timeframes (kidney 12 months; other organs six months).
- Infectious disease screening (CMV, VZV, EBV, Hepatitis B/C, HIV, RPR, TB testing) within one year as applicable.
- Organ‑specific testing per organ (e.g., MELD/INR for liver; GFR for kidney; echo/right heart cath for heart; PFTs and 6‑minute walk for lung).
- Detailed psychosocial evaluation within 12 months for kidney and six months for other transplants; annual dental evaluation and clearance.
Transplant Center Requirements
Center and program requirements referenced; specific accreditation/volume criteria not listed here
Policy references transplant service providers and transplant programs and notes applicable accreditation and regulatory standards (FACT, OPTN/UNOS, CMS) but does not list specific center accreditation or volume requirements in this excerpt.
Post-Transplant Follow-Up Coverage
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.